Publicaciones en colaboración con investigadores/as de Cleveland Clinic (2)

2023

  1. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

    The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422

2021

  1. Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis

    JCI Insight, Vol. 6, Núm. 11